GXQ-13751-07027
1 vaccination
1 coded response
1 check-in
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 104 / NY
- Registered
- 2021-01-05
- Relationship
- Self
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Survey response — days 1–6 daily, dose 1MedDRA: Vaginal haemorrhage — Feeling: Fair · Site: Pain, Swelling · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Vaginal bleedingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-07
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Get care from a doctor or other healthcare professionalno matching call case
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech |
Call center
1 check-in flagged for a call with no call center case on record
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Vaginal bleeding
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Vaginal haemorrhage | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release